Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Sara T Lo und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of California Davis School of Veterinary Medicine, William R. Prichard Veterinary Medical Teaching Hospital, Davis, California, USA. Hauptthemen laut MEDLINE: Rivaroxaban, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EveryCat Health Foundation, National Institutes of Health T35.
Abstract (Originalsprache)
Background
Dual antithrombotic treatment (DAT) with clopidogrel and rivaroxaban sometimes is prescribed to cats with hypertrophic cardiomyopathy at risk of thromboembolism. To date, no studies have evaluated their combined effects on platelet function. Objectives/Hypothesis Evaluate the safety of DAT in healthy cats and compare, ex vivo, platelet-dependent thrombin generation and agonist-induced platelet activation and aggregation in cats treated with clopidogrel, rivaroxaban, or DAT. We hypothesized that DAT would safely modulate agonist-induced platelet activation and aggregation more effectively than single agent treatment. Animals Nine apparently healthy 1-year-old cats selected from a research colony.
Methods
Unblinded, nonrandomized ex vivo cross-over study. All cats received 7 days of rivaroxaban (0.6 ± 0.1 mg/kg PO), clopidogrel (4.7 ± 0.8 mg/kg PO), or DAT with defined washout periods between treatments. Before and after each treatment, adenosine diphosphate (ADP)- and thrombin-induced platelet P-selectin expression was evaluated using flow cytometry to assess platelet activation. Platelet-dependent thrombin generation was measured by fluorescence assay. Platelet aggregation was assessed using whole blood impedance platelet aggregometry.
Results
No cats exhibited adverse effects. Of the 3 treatments, only DAT significantly decreased the number of activated platelets (P = .002), modulated platelet activation in response to thrombin (P = .01), dampened thrombin generation potential (P = .01), and delayed maximum reaction velocity (P = .004) in thrombin generation. Like clopidogrel, DAT inhibited ADP-mediated platelet aggregation. However, rivaroxaban alone resulted in increased aggregation and activation in response to ADP. Conclusion and Clinical Importance Treatment combining clopidogrel and rivaroxaban (DAT) safely decreases platelet activation, platelet response to agonists, and thrombin generation in feline platelets more effectively than monotherapy with either clopidogrel or rivaroxaban.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of California Davis School of Veterinary Medicine, William R. Prichard Veterinary Medical Teaching Hospital, Davis, California, USA.
- Surgical and Radiological Sciences, University of California, Davis, Davis, California, USA.
- Surgical and Radiological Sciences, University of California Davis School of Veterinary Medicine, Davis, California, USA.
- Medicine and Epidemiology, University of California, Davis, Davis, California, USA.
- Medicine and Epidemiology, University of California Davis School of Veterinary Medicine, Davis, California, USA.
- University of California Davis School of Veterinary Medicine - VME, UC Davis 2108 Tupper Hall, One Shields Avenue, Davis, California 95616-5270, USA.
ORCID-Profile: Sara T Lo, Ronald H L Li
Förderung
- EveryCat Health Foundation
- National Institutes of Health T35
Zitieren
APA
Lo, S. T., Li, R. H. L., Georges, C. J., Nguyen, N., Chen, C. K., Stuhlmann, C., Oldach, M. S., Rivas, V. N., Fousse, S., Harris, S. P., & Stern, J. A. (2023). Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16727
Vancouver
Lo ST, Li RHL, Georges CJ, Nguyen N, Chen CK, Stuhlmann C, et al. Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16727
BibTeX
@article{Lo2023,
author = {Lo, Sara T and Li, Ronald H L and Georges, Catherine J and Nguyen, Nghi and Chen, Cheyenne K and Stuhlmann, Claire and Oldach, Maureen Sigmund and Rivas, Victor Noel and Fousse, Samantha and Harris, Samantha P and Stern, Joshua A},
title = {Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16727}
}
EUVIMED